Monday, May 12, 2025
spot_img

Melexis: update on the share buy-back program

Press release – Regulated Information


Ieper, Belgium – 12 May 2025, 17.45 hrs CET

Further to the initiation of the share buy-back program announced on 10 December 2024, Melexis reports the purchase of 47,500 Melexis shares on Euronext Brussels in the period from 2 to 9 May 2025.

Trade date Total shares purchased Average price (€) Min price (€) Max price (€) Buyback amount (€)
2/5/2025 8,500 54.52 53.25 54.95 463,450
5/5/2025 9,000 54.29 54.05 55.05 488,586
6/5/2025 8,000 53.24 52.75 54.30 425,894
7/5/2025 8,000 53.49 52.95 53.70 427,919
8/5/2025 7,000 54.48 53.80 55.10 381,340
9/5/2025 7,000 55.24 55.00 55.75 386,701
TOTAL 47,500 54.19 52.75 55.75 2,573,890

As a result of purchases made since the launch of the share buy-back program for up to 850,000 shares, Melexis now holds 384,700 treasury shares.

Powered by SlickText.com

Hot this week

Orbit International Corp. Reports 2025 First Quarter Results

First Quarter 2025 Net Loss of $2,152,000 ($0.65 loss...

Share buy-back program

COMPANY ANNOUNCEMENT NO 26/2025 - May 12, 2025 ...

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025

Conference Call Scheduled for Thursday, May 15, 2025 at...

Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial

Adds nine additional countries to the Company’s ongoing pivotal...

Barnes & Noble Education Announces Surge in New Campus Store Partnerships

Over 20 new institutions across a mix of two-...

Topics

Orbit International Corp. Reports 2025 First Quarter Results

First Quarter 2025 Net Loss of $2,152,000 ($0.65 loss...

Share buy-back program

COMPANY ANNOUNCEMENT NO 26/2025 - May 12, 2025 ...

Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial

Adds nine additional countries to the Company’s ongoing pivotal...

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

Significant Neurological Expertise to Help Drive Clinical Development Strategy and...
spot_img

Related Articles

Popular Categories

spot_img